COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 202 filers reported holding COHERUS BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $67 | -76.9% | 15,694 | -63.0% | 0.01% | -70.4% |
| Q1 2023 | $290 | -99.9% | 42,413 | +106.9% | 0.03% | +42.1% |
| Q3 2022 | $197,000 | -36.0% | 20,500 | -51.8% | 0.02% | -45.7% |
| Q2 2022 | $308,000 | -21.2% | 42,489 | +73.5% | 0.04% | -18.6% |
| Q4 2021 | $391,000 | -32.9% | 24,483 | -38.7% | 0.04% | -34.8% |
| Q1 2021 | $583,000 | +13.9% | 39,924 | +26.4% | 0.07% | -34.0% |
| Q1 2020 | $512,000 | +25.2% | 31,586 | +38.9% | 0.10% | +51.5% |
| Q4 2019 | $409,000 | +17.9% | 22,734 | +32.7% | 0.07% | +8.2% |
| Q3 2019 | $347,000 | +17.6% | 17,128 | -20.8% | 0.06% | +27.1% |
| Q1 2019 | $295,000 | +136.0% | 21,630 | +57.3% | 0.05% | +118.2% |
| Q4 2018 | $125,000 | -78.6% | 13,754 | -61.1% | 0.02% | -72.8% |
| Q3 2018 | $583,000 | +202.1% | 35,343 | +156.0% | 0.08% | +179.3% |
| Q2 2018 | $193,000 | – | 13,805 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 650,000 | $10,374,000 | 2.09% |
| CM Management, LLC | 125,000 | $1,995,000 | 1.51% |
| Perceptive Advisors | 10,815,596 | $172,616,000 | 1.33% |
| Bridge City Capital, LLC | 163,198 | $2,605,000 | 1.07% |
| Phocas Financial Corp. | 514,438 | $8,210,000 | 1.04% |
| Redwood Investments, LLC | 709,184 | $11,319,000 | 0.89% |
| Aristotle Capital Boston, LLC | 2,087,187 | $33,312,000 | 0.78% |
| Knott David M Jr | 102,555 | $1,637,000 | 0.56% |
| Zebra Capital Management LLC | 16,746 | $267,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 7,381,116 | $117,803,000 | 0.42% |